Peptidyl-glutamyl peptide-hydrolyzing activity

Revision as of 13:46, 6 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Peptidyl-glutamyl peptide-hydrolyzing (PGPH) enzyme activity is a means of proteolysis that cleaves peptide bonds in proteins immediately after acidic or branched-chain amino acids. One of the three catalytic β subunits of the proteasome has PGPH activity and is strongly inhibited by the proteasome inhibitor epoxomicin.[1]

References

  1. Meng L, Mohan R, Kwok BHB, Elofsson M, Sin N, Crews CM. (1999). Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci USA 96(18): 10403-10408.

External links

Template:WikiDoc Sources